SOUTH SAN FRANCISCO, Calif., April 27 /PRNewswire-FirstCall/ -- Pain Therapeutics, Inc. , a biopharmaceutical company, today announced it will host a conference call to discuss first quarter 2006 financial results. The call will take place on Thursday, May 4th at 1:30 p.m. Pacific Time/4:30 p.m. Eastern Time.
To participate in the conference call, please dial 866-578-5801 (within the U.S.) or 617-213-8058 (outside the U.S.) fifteen minutes prior to the start of the call. The call reference number is 37288731. A playback of the conference call will be available following the live event. To access the playback, please dial 888-286-8010 (within the U.S.) or 617-801-6888 (outside the U.S.) and enter reservation number 72207618.
A webcast of the conference call will also be available online at www.paintrials.com.
About Pain Therapeutics, Inc.
We are a biopharmaceutical company that develops novel drugs. We have two drug candidates, Remoxy(TM) and Oxytrex(TM), in Phase III clinical programs. Both drugs target different segments of the multi-billion dollar market to treat severe chronic pain, such as persistent low-back pain or pain due to advanced stages of osteoarthritis.
Pain Therapeutics, Inc.
CONTACT: media, Carney Duntsch of Burns McClellan, +1-212-213-0006, forPain Therapeutics, Inc.; or Christi Waarich, Senior Manager of InvestorRelations of Pain Therapeutics, Inc., +1-650-825-3324, orcwaarich@paintrials.com
Web site: http://www.paintrials.com//
